Hoya Corp (HOCPY)
117.00
-0.49
(-0.41%)
USD |
OTCM |
Apr 26, 13:30
Hoya Cash from Financing (TTM): -1.060B for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.060B |
September 30, 2023 | -1.014B |
June 30, 2023 | -1.118B |
March 31, 2023 | -1.441B |
December 31, 2022 | -1.679B |
September 30, 2022 | -1.661B |
June 30, 2022 | -1.277B |
March 31, 2022 | -950.64M |
December 31, 2021 | -793.48M |
September 30, 2021 | -1.125B |
June 30, 2021 | -1.130B |
March 31, 2021 | -1.091B |
December 31, 2020 | -804.93M |
September 30, 2020 | -569.14M |
June 30, 2020 | -627.27M |
March 31, 2020 | -786.37M |
December 31, 2019 | -675.78M |
September 30, 2019 | -568.30M |
June 30, 2019 | -483.92M |
March 31, 2019 | -295.79M |
December 31, 2018 | -398.01M |
September 30, 2018 | -568.10M |
June 30, 2018 | -1.061B |
March 31, 2018 | -1.059B |
December 31, 2017 | -955.93M |
Date | Value |
---|---|
September 30, 2017 | -715.30M |
June 30, 2017 | -533.88M |
March 31, 2017 | -594.49M |
December 31, 2016 | -1.108B |
September 30, 2016 | -1.352B |
June 30, 2016 | -1.084B |
March 31, 2016 | -1.346B |
December 31, 2015 | -858.52M |
September 30, 2015 | -584.99M |
June 30, 2015 | -833.85M |
March 31, 2015 | -785.78M |
December 31, 2014 | -752.86M |
September 30, 2014 | -834.00M |
June 30, 2014 | -554.59M |
March 31, 2014 | -277.50M |
December 31, 2013 | -268.04M |
September 30, 2013 | -282.32M |
June 30, 2013 | -796.03M |
March 31, 2013 | -834.89M |
December 31, 2012 | -1.017B |
September 30, 2012 | -906.82M |
June 30, 2012 | -565.64M |
December 31, 2011 | -547.34M |
September 30, 2011 | -502.73M |
June 30, 2011 | -545.03M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.679B
Minimum
Dec 2022
-483.92M
Maximum
Jun 2019
-992.40M
Average
-1.014B
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
Takeda Pharmaceutical Co Ltd | -2.274B |
Nxera Pharma Co Ltd | 344.46M |
PeptiDream Inc | 1.883M |
Stemcell Holdings Inc | -0.0934M |
Healios KK | 23.78M |